Cwm, LLC Anavex Life Sciences Corp. Transaction History

Cwm, LLC

$24.1 Billion
Q4 2024

A detailed history of Cwm, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Cwm, LLC holds 3,087 shares of AVXL stock, worth $26,671. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,087

Previous 3,450 10.52%

Holding current value

$26,671

Previous $20,000 65.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$5.11 - $12.56 $1,854 - $4,559	-363 Reduced 10.52%	3,087 $33,000
Q3 2024 Oct 08, 2024	BUY	$4.11 - $7.04 $8,647 - $14,812	2,104 Added 156.32%	3,450 $20,000
Q2 2024 Jul 09, 2024	BUY	$3.39 - $5.02 $3,952 - $5,853	1,166 Added 647.78%	1,346 $6,000
Q1 2024 Apr 05, 2024	SELL	$4.55 - $6.75 $295 - $438	-65 Reduced 26.53%	180 $1,000
Q4 2023 Feb 01, 2024	SELL	$5.04 - $9.95 $2,081 - $4,109	-413 Reduced 62.77%	245 $2,000
Q3 2023 Oct 11, 2023	BUY	$6.55 - $9.37 $1,617 - $2,314	247 Added 60.1%	658 $4,000
Q2 2023 Aug 03, 2023	SELL	$7.66 - $9.5 $191 - $237	-25 Reduced 5.73%	411 $3,000
Q1 2023 Apr 28, 2023	BUY	$8.32 - $11.75 $2,912 - $4,112	350 Added 406.98%	436 $4,000
Q4 2022 Feb 01, 2023	BUY	$7.65 - $14.43 $657 - $1,240	86 New	86 $1,000
Q1 2022 Apr 21, 2022	SELL	$9.74 - $17.69 $272 - $495	-28 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$16.88 - $23.31 $2,903 - $4,009	-172 Reduced 86.0%	28 $0
Q1 2021 Sep 15, 2021	BUY	$5.17 - $16.13 $1,034 - $3,226	200 New	200 $5,000
Q1 2021 Apr 27, 2021	SELL	$5.17 - $16.13 $1,034 - $3,226	-200 Closed	0 $0
Q4 2020 Sep 15, 2021	SELL	$4.01 - $7.58 $7,218 - $13,644	-1,800 Reduced 90.0%	200 $5,000
Q4 2020 Jan 27, 2021	BUY	$4.01 - $7.58 $7,218 - $13,644	1,800 Added 900.0%	2,000 $11,000
Q3 2020 Sep 15, 2021	SELL	$3.8 - $5.0 $22,040 - $29,000	-5,800 Reduced 96.67%	200 $5,000
Q3 2020 Oct 19, 2020	BUY	$3.8 - $5.0 $22,040 - $29,000	5,800 Added 2900.0%	6,000 $27,000
Q2 2020 Sep 15, 2021	SELL	$2.62 - $5.2 $16,506 - $32,760	-6,300 Reduced 96.92%	200 $5,000
Q2 2020 Jul 22, 2020	BUY	$2.62 - $5.2 $16,506 - $32,760	6,300 Added 3150.0%	6,500 $32,000
Q1 2020 Sep 15, 2021	SELL	$2.38 - $5.81 $13,804 - $33,698	-5,800 Reduced 96.67%	200 $5,000
Q1 2020 Apr 28, 2020	BUY	$2.38 - $5.81 $13,804 - $33,698	5,800 Added 2900.0%	6,000 $19,000
Q4 2019 Sep 14, 2021	SELL	$2.31 - $3.14 $13,398 - $18,212	-5,800 Reduced 96.67%	200 $5,000
Q4 2019 Jan 27, 2020	BUY	$2.31 - $3.14 $13,398 - $18,212	5,800 Added 2900.0%	6,000 $16,000
Q3 2019 Sep 14, 2021	SELL	$2.22 - $3.9 $12,876 - $22,620	-5,800 Reduced 96.67%	200 $5,000
Q3 2019 Oct 22, 2019	BUY	$2.22 - $3.9 $12,876 - $22,620	5,800 Added 2900.0%	6,000 $19,000
Q2 2019 Sep 14, 2021	SELL	$2.75 - $3.7 $24,200 - $32,560	-8,800 Reduced 97.78%	200 $5,000
Q2 2019 Jul 31, 2019	BUY	$2.75 - $3.7 $24,200 - $32,560	8,800 Added 4400.0%	9,000 $30,000
Q1 2019 Sep 02, 2021	SELL	$1.68 - $3.42 $9,744 - $19,836	-5,800 Reduced 96.67%	200 $0
Q4 2018 Jan 25, 2019	BUY	$1.25 - $2.75 $7,500 - $16,500	6,000 New	6,000 $9,000

Others Institutions Holding AVXL

# of Institutions

163

Shares Held

27.5M

Call Options Held

515K

Put Options Held

838K

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $673M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account